OPKO finalizes Ophthalmic Technologies purchase

Article

OPKO Health has completed its acquisition of Ophthalmic Technologies Inc. (OTI), a privately owned Canadian company.

OPKO Health has completed its acquisition of Ophthalmic Technologies Inc. (OTI), a privately owned Canadian company.

OTI markets a full line of ultrasound and imaging products and its new Spectral SLO-OCT system provides confocal fundus imaging allowing for accurate point-to-point registration and orientation of the B-Scan image in real-time.

OTI's new system offers a wide range of clinical possibilities with its ability to provide high resolution B-Scan images, 3D Tomographic and Topographic data, and Optic Nerve and RNFL data for monitoring glaucoma patients.

Recent Videos
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
© 2024 MJH Life Sciences

All rights reserved.